UNSPECIFIED INGREDIENT for Coronary artery disease: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 57 adverse event reports in the FDA FAERS database where UNSPECIFIED INGREDIENT was used for Coronary artery disease.
Most Reported Side Effects for UNSPECIFIED INGREDIENT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 2,090 | 8.0% | 2,089 | 308 |
| Off label use | 1,306 | 5.0% | 324 | 483 |
| Drug ineffective | 1,227 | 4.7% | 154 | 338 |
| Completed suicide | 1,190 | 4.6% | 1,189 | 170 |
| Nausea | 1,041 | 4.0% | 234 | 514 |
| Fatigue | 1,020 | 3.9% | 167 | 402 |
| Dyspnoea | 934 | 3.6% | 270 | 594 |
| Pneumonia | 903 | 3.5% | 310 | 719 |
| Asthenia | 894 | 3.4% | 237 | 506 |
| Vomiting | 877 | 3.4% | 244 | 528 |
| Diarrhoea | 821 | 3.1% | 152 | 457 |
| Pain | 701 | 2.7% | 128 | 299 |
| Dizziness | 692 | 2.6% | 88 | 283 |
| Headache | 681 | 2.6% | 125 | 261 |
| Pyrexia | 658 | 2.5% | 140 | 499 |
Other Indications for UNSPECIFIED INGREDIENT
Product used for unknown indication (6,768)
Rheumatoid arthritis (394)
Non-small cell lung cancer (276)
Cardiac failure (261)
Type 2 diabetes mellitus (229)
Diffuse large b-cell lymphoma (210)
Covid-19 (207)
Malignant melanoma (186)
Hiv infection (185)
Suspected suicide (172)
Other Drugs Used for Coronary artery disease
ASPIRIN (2,758)
CLOPIDOGREL BISULFATE (1,584)
EVOLOCUMAB (1,266)
ATORVASTATIN (891)
RIVAROXABAN (847)
DILTIAZEM (664)
ROSUVASTATIN (600)
TICAGRELOR (520)
QUINAPRIL (511)
AMLODIPINE (486)